Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
about
Novel agents in the treatment of multiple myeloma: a review about the futurePrevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis.Posttransplant maintenance therapy in multiple myeloma: the changing landscape.Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and against.
P2860
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
@ast
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
@en
type
label
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
@ast
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
@en
prefLabel
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
@ast
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
@en
P2093
P2860
P356
P1476
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
@en
P2093
Craig C Hofmeister
Don M Benson
Douglas W Sborov
Kristina Humphries
Mindy A Bowers
Nita Williams
Steven Devine
Ying Huang
Yvonne Efebera
P2860
P356
10.1111/BJH.13527
P407
P577
2015-06-08T00:00:00Z